Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Toshiki Kameda, Hiraku Kumamaru, Shiori Nishimura, Shun Kohsaka & Hiroaki Miyata. (2020) Use of oral antidiabetic drugs in Japanese working-age patients with type 2 diabetes mellitus: dosing pattern for metformin initiators. Current Medical Research and Opinion 36:5, pages 749-756.
Read now
Read now
Tomoko Hayashi, Hiroki Murayama, Yohei Shinfuku, Tomoko Taniguchi, Isao Tsumiyama & Naotsugu Oyama. (2020) Safety and efficacy of vildagliptin: 52-week post-marketing surveillance of Japanese patients with type 2 diabetes in combination with other oral antidiabetics and insulin. Expert Opinion on Pharmacotherapy 21:1, pages 121-130.
Read now
Read now
Articles from other publishers (10)
Swetha R. Reghunath, Muhammed Rashid, Viji Pulikkel Chandran, Girish Thunga, K.N. Shivashankar & Leelavathi D. Acharya. (2023) Factors contributing to the adverse drug reactions associated with the dipeptidyl peptidase-4 (DPP-4) inhibitors: A scoping review. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 17:7, pages 102790.
Crossref
Crossref
Hongjin Zhai, Shuo Zhang, Maxwell Ampomah-Wireko, Huanhuan Wang, Yaquan Cao, Pu Yang, Yingxue Yang, Firas Obald Arhema Frejat, Lihong Wang, Bingbing Zhao, Changzhong Ren & Chunli Wu. (2022) Pyrazole: An Important Core in Many Marketed and Clinical Drugs. Russian Journal of Bioorganic Chemistry 48:6, pages 1175-1189.
Crossref
Crossref
Jaehyun Bae, Kee‐Ho Song, Jong Suk Park, Jae Hyuk Lee, In‐Kyung Jeong, Hyun Jin Kim, Young‐Hyo Lim, Jae‐Hyoung Cho, Sung Hee Choi, Yoon‐Sok Chung & Eun Seok Kang. (2021) Safety and effectiveness of linagliptin in Korean patients with type 2 diabetes: A postmarketing surveillance study. Diabetes, Obesity and Metabolism 23:5, pages 1208-1212.
Crossref
Crossref
Sujoy Ghosh, Mangesh Tiwaskar, Rajiv Chawla, Shalini Jaggi, Arthur Asirvatham & Vijay Panikar. (2020) Teneligliptin Real-World Effectiveness Assessment in Patients with Type 2 Diabetes Mellitus in India: A Retrospective Analysis (TREAT-INDIA 2). Diabetes Therapy 11:10, pages 2257-2268.
Crossref
Crossref
Takashi Kadowaki, Masakazu Haneda, Hiroshi Ito, Kazuyo Sasaki & Yuka Yamada. (2020) Long-Term Safety and Efficacy of Teneligliptin in Elderly Patients with Type 2 Diabetes: Subgroup Analysis of a 3-Year Post-Marketing Surveillance in Japan. Advances in Therapy 37:5, pages 2477-2492.
Crossref
Crossref
Takashi Kadowaki, Masakazu Haneda, Hiroshi Ito, Kazuyo Sasaki, Miyuki Matsukawa & Yuka Yamada. (2019) Long-Term, Real-World Safety and Efficacy of Teneligliptin: A Post-Marketing Surveillance of More Than 10,000 Patients with Type 2 Diabetes in Japan. Advances in Therapy 37:3, pages 1065-1086.
Crossref
Crossref
Antonio Ceriello, Valeria De Nigris, Hiroaki Iijima, Takahiro Matsui & Maki Gouda. (2019) The Unique Pharmacological and Pharmacokinetic Profile of Teneligliptin: Implications for Clinical Practice. Drugs 79:7, pages 733-750.
Crossref
Crossref
Masakazu Haneda, Takashi Kadowaki, Hiroshi Ito, Kazuyo Sasaki, Sonoe Hiraide, Manabu Ishii, Miyuki Matsukawa & Makoto Ueno. (2018) Safety and Efficacy of Teneligliptin in Patients with Type 2 Diabetes Mellitus and Impaired Renal Function: Interim Report from Post-marketing Surveillance. Diabetes Therapy 9:3, pages 1083-1097.
Crossref
Crossref
Takashi Kadowaki, Masakazu Haneda, Hiroshi Ito, Kazuyo Sasaki, Sonoe Hiraide, Miyuki Matsukawa & Makoto Ueno. (2018) Relationship of Eating Patterns and Metabolic Parameters, and Teneligliptin Treatment: Interim Results from Post-marketing Surveillance in Japanese Type 2 Diabetes Patients. Advances in Therapy 35:6, pages 817-831.
Crossref
Crossref
Takumi Minezumi, Shin-ichi Takeda, Yusuke Igarashi, Kentaro Sato, Yoshiaki Murakami & Daisuke Nagata. (2018) Hypoglycemic Coma in a Hemodialysis Patient Receiving Blood Glucose-Lowering Therapy With the Single Agent Teneligliptin. Clinical Medicine Insights: Case Reports 11, pages 117954761876335.
Crossref
Crossref